openPR Logo
Press release

Endometriosis Treatment Market Outlook, and Opportunity Analysis, 2018 – 2026

08-18-2018 11:35 AM CET | Health & Medicine

Press release from: Coherent Market Insights

Endometriosis Treatment Market Outlook, and Opportunity

Endometriosis is a painful medical condition in which the tissue that lines in the inner part of the uterus i.e. endometrium grows outside the uterus. Endometriosis tissue is found in fallopian tubes, ovaries, and tissue lining the pelvis. In endometriosis, endometrial tissue which is displaced acts in the usual way i.e. it thickens, breaks down and eventually bleeds like in every menstrual cycle. As the displaced tissue has no other way to exit the body it gets trapped outside the uterus. Involvement of ovaries in endometriosis leads to formation of cysts called endometriomas. Due to this the surrounding tissues form an adhesion (abnormal bands of fibrous tissue that cause pelvic organs and tissues to stick to each other) or a scar tissue near the ovaries.

Request Sample Copy of this Business Report @ https://www.coherentmarketinsights.com/insight/request-sample/1999

Primary symptom of endometriosis is pain in pelvic area, which is associated with menstrual cycle. Other signs and symptoms of endometriosis include pain in pelvic region before menstrual cycle, pain in lower back during menstrual period, pain after intercourse in pelvic area, pain during urination, excessive bleeding between periods, fatigue, diarrhea, constipation, and nausea during menstrual cycle. Risk factors of endometriosis include infertility, onset of menstrual cycle at early age, short menstrual cycles, menopause at an older age, low body mass index, uterine abnormalities, and medical condition, which prevents normal passage of menstrual flow.

Endometriosis Treatment Market Drivers:-

Increasing research activities for development of new drugs for the global endometriosis treatment market is expected to be a major driver for growth of the market over the forecast period. For instance in 2017, AbbVie, biopharmaceutical company in co-operation with Neurocrine Biosciences Inc submitted New Drug Application (NDA) to the U.S. Food and drug Administration (FDA) for a new drug named elagolix. It is an orally administering gonadotropin releasing hormone antagonist, which is being evaluated for management of pain associated with endometriosis.

Launch of products by manufacturer is also expected to drive global endometriosis treatment market growth. For instance, in 2018, LASCO distributors in association with Bayer healthcare launched new drug visanne, which is indicated for endometriosis treatment.

Other factors such as increase in prevalence of endometriosis, robust pipeline, awareness about endometriosis is expected to support endometriosis treatment market growth. For instance, Triptoreline sponsored by University Hospital, Rouen is in Phase 3 Clinical Trials; Triptoreline cures deep endometriosis in the rectum , Myovant Sciences has Relugolix in phase 3 Clinical Trials; Relugolix ceases non-menstrual pelvic pain, Indocyannine Green sponsored by University Hospital in Phase 4 Clinical Trials; Indocyannine Green treats recto vaginal endometriosis, Dienogest sponsored by the University Of Hong Kong is in Phase 4 Clinical Trials; dienogest stops the reoccurance of endometriosis cyst, Merional sponsored by Cario University is in phase 3 Clinical Trials; Merional controls intrauterine insemination cycles in women having endometriosis.

According to a survey conducted by National Center for Biotechnology Information (NCBI), 2014, endometriosis is estimated to affect 10% of female in the reproductive age and more than 50% in infertility patients, which in turn is expected to fuel growth of the endometriosis treatment market over the forecast period.

Availability of alternative treatment options such as Intrauterine Systems (IUS) is key factor restarting growth of the market. IUS is a T-shaped device inserted in womb by the doctor. Moreover, treatment of endometriosis consists of use of oral contraceptives or GnRH agonists. Most of these therapies have adverse effects on the body due to hormonal changes and it also includes the risk of recurrence of endometriosis.

Endometriosis Treatment Market Regional Analysis:-

Asia Pacific endometriosis treatment market is projected to witness significant growth over the forecast period due to initiative taken by the government to improve health of women in Australia. According to the George institute of global health, in 2018, government of Australia allocated about US$ 2.5 million for research in the field of endometriosis. It includes around US$ 120,000 for campaigns, which will provide education and awareness regarding endometriosis and also a research grant for National Health and Medical Research Council.

Access Table of Content (TOC) Of the Report @ https://www.coherentmarketinsights.com/ongoing-insight/toc/1999

Europe region is projected to witness growth in the endometriosis market over the forecast period due to robust drugs pipeline. For instance, Pleyris sponsored by University Magna Graecia is in Phase 3. According to a study conducted by BJOC: An International Journal of Obstetrics and Gynaecology, 2015, in Europe endometriosis affects more than 10% of premenopausal women and 30-50% of the women suffering from symptoms of endometriosis. Increasing number of endometriosis patients is fueling Europe endometriosis treatment market growth.

Endometriosis Treatment Market Key Players:-

Key players operating in global endometriosis treatment market include Astra Zeneca Plc., Eli Lilly and Company, AStellas Pharma, Bayer AG, Meditrina Pharmaceuticals, Abbvie, PfizerInc, Takeda Pharmaceutica, and Neurocrine Biosciences Inc

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Endometriosis Treatment Market Outlook, and Opportunity Analysis, 2018 – 2026 here

News-ID: 1186675 • Views: 700

More Releases from Coherent Market Insights

Computational Biology Market - Detailed Analysis of Current and Future Industry …
Global Computational Biology Market Insights, Forecast to 2027 is latest research study re-leased by CMI evaluating the market, highlighting opportunities, risk side analysis, and lever-aged with strategic and tactical decision-making support. The study provides information on market trends and development, drivers, capacities, technologies, and on the changing investment structure of the Global Computational Biology Market. Some of the key players profiled in the study are Accelrys, Certara, L.P., Chemical Computing
Telerehabilitation Systems Market - Detailed Analysis of Current and Future Indu …
Global Telerehabilitation Systems Market Insights, Forecast to 2027 is latest research study re-leased by CMI evaluating the market, highlighting opportunities, risk side analysis, and lever-aged with strategic and tactical decision-making support. The study provides information on market trends and development, drivers, capacities, technologies, and on the changing investment structure of the Global Telerehabilitation Systems Market. Some of the key players profiled in the study are Reflexion Health, Inc., 270 Vision
Personal Emergency Response Systems Market - Detailed Analysis of Current and Fu …
Global Personal Emergency Response Systems Market Insights, Forecast to 2027 is latest research study re-leased by CMI evaluating the market, highlighting opportunities, risk side analysis, and lever-aged with strategic and tactical decision-making support. The study provides information on market trends and development, drivers, capacities, technologies, and on the changing investment structure of the Global Personal Emergency Response Systems Market. Some of the key players profiled in the study are Koninklijke
Wearable Patch Market - Detailed Analysis of Current and Future Industry Figures …
Global Wearable Patch Market Insights, Forecast to 2027 is latest research study re-leased by CMI evaluating the market, highlighting opportunities, risk side analysis, and lever-aged with strategic and tactical decision-making support. The study provides information on market trends and development, drivers, capacities, technologies, and on the changing investment structure of the Global Wearable Patch Market. Some of the key players profiled in the study are Medtronic Plc, Hill-Rom Holdings, Inc.

All 5 Releases


More Releases for Endometriosis

Endometriosis Market Trends, Size, Forecast - 2018-2023
Endometriosis is a painful disorder in which the layer of tissue that normally surfaces inside the uterus, starts growing outside the uterus. This mainly occurs on the fallopian tubes, ovaries, and tissue around the uterus; however, in exceptional cases it may occur in other parts of the body. The endometriosis leads to various physical symptoms such as severe menstrual cramps, nausea and vomiting, fatigue, diarrhea, constipation, long-term pelvic pain, and
Global Endometriosis Treatment Market Insights, Forecast to 2025
Market Research Report Store offers a latest published report on Endometriosis Treatment Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. The report contains 158 pages which highly exhibit on current market analysis scenario, upcoming as well as future opportunities, revenue growth, pricing and profitability. Click to view the full report TOC, figure and tables: https://www.marketresearchreportstore.com/reports/817758/global-endometriosis-treatment-market-insights   Therapies used to treat endometriosis include: Hormonal contraceptives. Birth
Endometriosis-Pipeline Review H2 2018
Endometriosis-Pipeline Review, H2 2018 Summary Publisher's latest Pharmaceutical and Healthcare disease pipeline guide Endometriosis-Pipeline Review, H2 2018, provides an overview of the Endometriosis (Women's Health) pipeline landscape. Endometriosis is an often painful disorder in which tissue that normally lines the inside of uterus (endometrium) grows outside uterus (endometrial implant). Symptoms include pelvic pain, menstrual cramps, inflammation, infertility and abnormal bleeding. Risk factors age, uterine abnormalities, history of pelvic infection and family history. Treatment
Global Endometriosis Market Research and Forecast 2018-2023
Endometriosis is a painful disorder in which the layer of tissue that normally surfaces inside the uterus, starts growing outside the uterus. This mainly occurs on the fallopian tubes, ovaries, and tissue around the uterus; however, in exceptional cases it may occur in other parts of the body. The endometriosis leads to various physical symptoms such as severe menstrual cramps, nausea and vomiting, fatigue, diarrhea, constipation, long-term pelvic pain, and
Endometriosis Treatment Market Intelligence with Competitive Landscape 2024
Endometriosis is a medical condition in which the tissue that forms normal lining of uterus appears outside the uterus cavity and may involve ovaries, bowel, or tissue lining of the pelvic floor. This disease affects over 170 million women across the globe. Endometriosis has an unclear etiology and complex symptoms. Hence, the endometriosis treatment market is projected to grow substantially due to increase in number of cases for endometriosis and
Endometriosis Market to Register Substantial Expansion by 2018
Endometriosis is a medical condition in which the tissue that forms normal lining of uterus appears outside the uterus cavity and may involve ovaries, bowel or tissue lining of the pelvic floor. This disease affects over 170 million females across the globe. Endometriosis has an unclear etiology and complex symptoms. These factors contribute in difficulties for timely diagnosis and obstruct the drug discovery processes. Endometriosis is a major cause of